Home › Ischemic Stroke › NCT05301140
Vivistim Registry for Paired VNS Therapy (GRASP)
Who can join
Ages 22 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients implanted with the Vivistim System for upper limb deficits associated with an ischemic stroke Exclusion Criteria: * Not eligible for surgery
About the study
The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process. Physicians or sites will receive appropriate remuneration for the effort and cost involved in collecting and transmitting this data to MicroTransponder Inc.
What is being tested
- Vivistim System (device)
Sponsor: MicroTransponder Inc. · Participants: 1,000 · Started: Mar 15, 2023
Contact the study team
- Brent Tarver, BSEE · Phone: 8556289375
- Diana Hansen · Phone: 8556289375
Official record on ClinicalTrials.gov — NCT05301140
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.